Hwabao WP CSI Subdivision Chemical Industry Theme ETF(516020) rises 2.17%, with a scale increase of 157 million yuan over the past 2 weeks
NewTimeSpace (newtimespace.com) News, as of 10:59 on June 24, 2026, HuaBao Chemical ETF (516020) rose 2.17%, with the latest price at 0.94 yuan. Over a longer time frame, as of June 23, 2026, the ETF accumulated a gain of 0.76% over the past week.
In terms of liquidity, HuaBao Chemical ETF recorded an intraday turnover rate of 3.22% and a trading volume of 115 million yuan. Over a longer time frame, as of June 23, the ETF's average daily trading volume over the past week reached 245 million yuan, ranking in the top 2 among comparable funds.
In terms of scale, HuaBao Chemical ETF saw a significant increase of 157 million yuan in scale over the past two weeks, with the new scale increase ranking 3/6 among comparable funds. (Data source: Wind)
In terms of shares, HuaBao Chemical ETF experienced a significant increase of 3.108 billion units in share count over the past year, with the new share increase ranking 3/6 among comparable funds. (Data source: Wind)
Data shows that leveraged funds are continuously positioning. The latest margin financing purchase amount of HuaBao Chemical ETF reached 6.8328 million yuan, with the latest margin financing balance standing at 34.6443 million yuan. (Data source: Wind)
As of June 23, the net value of HuaBao Chemical ETF rose by 53.46% over the past two years. From the perspective of return capability, as of June 23, 2026, since its inception, the ETF achieved a highest single-month return of 21.66%, a longest streak of consecutive up months of 10 months, a maximum cumulative gain during that streak of 75.49%, and an average return of 6.55% in up months. As of June 23, 2026, the ETF's annualized excess return over its benchmark for the past three months was 3.67%, ranking in the top 2/6 among comparable funds.
As of June 18, 2026, the one-year Sharpe ratio of HuaBao Chemical ETF was 1.92.
In terms of drawdown, as of June 23, 2026, HuaBao Chemical ETF recorded a drawdown of 0.19% relative to its benchmark since the beginning of the year, reflecting lower drawdown risk among comparable funds.
In terms of fees, HuaBao Chemical ETF has a management fee rate of 0.50% and a custodian fee rate of 0.10%.
In terms of tracking accuracy, as of June 23, 2026, the one-year tracking error of HuaBao Chemical ETF was 0.026%, achieving relatively high tracking accuracy among comparable funds.
From a valuation perspective, the latest price-to-earnings (PE-TTM) ratio of the CSI Sub-Industry Chemical Industry Theme Index, which HuaBao Chemical ETF tracks, is only 24.39 times, standing at the 17.8% percentile over the past year. This means the valuation is lower than over 82.2% of the time in the past year, placing it at a historical low.
HuaBao Chemical ETF closely tracks the CSI Sub-Industry Chemical Industry Theme Index. The CSI Sub-Industry Theme Index Series consists of seven indices, including Sub-Industry Nonferrous Metals, Sub-Industry Machinery, etc. Each index selects the securities of listed companies that are relatively large in scale and have good liquidity from the relevant sub-industries as index constituents, in order to reflect the overall performance of the securities of listed companies in the relevant sub-industries.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- Mirae Asset Horizons S&P Crude Oil Futures Enhanced Er Etf(03097.HK) Falls 0.69% Intraday, Quoted at HK$7.205
- AI Chip Concept Stocks Watch | TSMC Announces Price Hike for Wafer Foundry Services; SMIC (00981.HK) Surges Nearly 10%
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 3.00%, AUM at HKD 730 Million
- NOVAKEN PHARM’s Hong Kong IPO Application Lapses, Focused on Dissolvable Microneedle and Nasal Inhalation Formulation Technologies
- W.I.S.E. CSI 300 china tracker(02827.HK) Rises 0.48% Intraday, AUM Stands at HK$889 Million